Transdermal Drug Delivery System Market Report – Research, Industry Analysis Reports and Market Demands

Global Transdermal Drug Delivery System Market Growth (Status and Outlook) 2019-2024

Request for Sample of this report

Buy now

Table of Content

2019-2024 Global Transdermal Drug Delivery System Market Report (Status and Outlook)

1 Scope of the Report

2 Executive Summary

2.1 World Market Overview
- 2.1.1 Global Transdermal Drug Delivery System Market Size 2014-2024
- 2.1.2 Transdermal Drug Delivery System Market Size CAGR by Region
2.2 Transdermal Drug Delivery System Segment by Type
- 2.2.1 Fentanyl
- 2.2.2 Nitroglycerin
- 2.2.3 Estradiol
- 2.2.4 Nicotine
- 2.2.5 Other
2.3 Transdermal Drug Delivery System Market Size by Type
- 2.3.1 Global Transdermal Drug Delivery System Market Size Market Share by Type (2014-2019)
- 2.3.2 Global Transdermal Drug Delivery System Market Size Growth Rate by Type (2014-2019)
2.4 Transdermal Drug Delivery System Segment by Application
- 2.4.1 OTC
- 2.4.2 Rx
2.5 Transdermal Drug Delivery System Market Size by Application
- 2.5.1 Global Transdermal Drug Delivery System Market Size Market Share by Application (2014-2019)
- 2.5.2 Global Transdermal Drug Delivery System Market Size Growth Rate by Application (2014-2019)

3 Global Transdermal Drug Delivery System by Players

3.1 Global Transdermal Drug Delivery System Market Size Market Share by Players
- 3.1.1 Global Transdermal Drug Delivery System Market Size by Players (2017-2019)
- 3.1.2 Global Transdermal Drug Delivery System Market Size Market Share by Players (2017-2019)
3.2 Global Transdermal Drug Delivery System Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Transdermal Drug Delivery System by Regions

4.1 Transdermal Drug Delivery System Market Size by Regions
4.2 Americas Transdermal Drug Delivery System Market Size Growth
4.3 APAC Transdermal Drug Delivery System Market Size Growth
4.4 Europe Transdermal Drug Delivery System Market Size Growth
4.5 Middle East & Africa Transdermal Drug Delivery System Market Size Growth

5 Americas

5.1 Americas Transdermal Drug Delivery System Market Size by Countries
5.2 Americas Transdermal Drug Delivery System Market Size by Type
5.3 Americas Transdermal Drug Delivery System Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Transdermal Drug Delivery System Market Size by Countries
6.2 APAC Transdermal Drug Delivery System Market Size by Type
6.3 APAC Transdermal Drug Delivery System Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe

7.1 Europe Transdermal Drug Delivery System by Countries
7.2 Europe Transdermal Drug Delivery System Market Size by Type
7.3 Europe Transdermal Drug Delivery System Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Transdermal Drug Delivery System by Countries
8.2 Middle East & Africa Transdermal Drug Delivery System Market Size by Type
8.3 Middle East & Africa Transdermal Drug Delivery System Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Transdermal Drug Delivery System Market Forecast

10.1 Global Transdermal Drug Delivery System Market Size Forecast (2019-2024)
10.2 Global Transdermal Drug Delivery System Forecast by Regions
- 10.2.1 Global Transdermal Drug Delivery System Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
10.7 Global Transdermal Drug Delivery System Forecast by Type
10.8 Global Transdermal Drug Delivery System Forecast by Application

11 Key Players Analysis

12 Research Findings and Conclusion

Description

Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.
The classification of Transdermal Drug Delivery System includes Fentanyl, Nitroglycerin, Estradiol, Nicotine and Other, and the revenue proportion of Fentanyl in 2016 is about 31.1%. Transdermal Drug Delivery System can be used for OTC, Rx. The most proportion of Transdermal Drug Delivery System is OTC, and the sales proportion is about 83.3% in 2016.

North America is the largest sales place, with a revenue market share nearly 41% in 2016. Following North America, Europe is the second largest sales place with the revenue market share of 28%. China and Japan are also important sales regions for Transdermal Drug Delivery System.

The unprecedented global shift in the adoption of unhealthy lifestyles is to be responsible for the high prevalence of chronic diseases, such as cancer and diabetes, which is expected to drive the clinical urgency to incorporate transdermal drug delivery systems in the future treatments. Moreover, the rising geriatric population base, which is highly susceptible to developing the aforementioned chronic diseases are expected to propel the demand for highly efficacious pharmacological drugs.

Market competition is intense. Hisamitsu, Mylan, Johnson & Johnson, Actavis, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

According to this study, over the next five years the Transdermal Drug Delivery System market will register a 13.4% CAGR in terms of revenue, the global market size will reach US$ 19000 million by 2024, from US$ 8950 million in 2019. In particular, this report presents the global revenue market share of key companies in Transdermal Drug Delivery System business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Transdermal Drug Delivery System market by product type, application, key companies and key regions.

This study considers the Transdermal Drug Delivery System value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Fentanyl
Nitroglycerin
Nicotine
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
OTC
Rx

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Hisamitsu
Mylan
GSK
Novartis
Teve (Actavis)
Johnson & Johnson
Lohmann
Teikoku Seiyaku
Bayer
Lingrui
Sanofi
Qizheng
Endo
Huarun 999
Haw Par
Nichiban
Mentholatum Company
Laboratoires Genevrier

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Transdermal Drug Delivery System market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Transdermal Drug Delivery System market by identifying its various subsegments.
Focuses on the key global Transdermal Drug Delivery System players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Transdermal Drug Delivery System with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Transdermal Drug Delivery System submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.